206 related articles for article (PubMed ID: 11179230)
1. The adenovirus E4-ORF4 splicing enhancer protein interacts with a subset of phosphorylated SR proteins.
Estmer Nilsson C; Petersen-Mahrt S; Durot C; Shtrichman R; Krainer AR; Kleinberger T; Akusjärvi G
EMBO J; 2001 Feb; 20(4):864-71. PubMed ID: 11179230
[TBL] [Abstract][Full Text] [Related]
2. Regulation of adenovirus alternative RNA splicing by dephosphorylation of SR proteins.
Kanopka A; Mühlemann O; Petersen-Mahrt S; Estmer C; Ohrmalm C; Akusjärvi G
Nature; 1998 May; 393(6681):185-7. PubMed ID: 9603524
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus E4 open reading frame 4-induced dephosphorylation inhibits E1A activation of the E2 promoter and E2F-1-mediated transactivation independently of the retinoblastoma tumor suppressor protein.
Mannervik M; Fan S; Ström AC; Helin K; Akusjärvi G
Virology; 1999 Apr; 256(2):313-21. PubMed ID: 10191196
[TBL] [Abstract][Full Text] [Related]
4. The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation.
Petersen-Mahrt SK; Estmer C; Ohrmalm C; Matthews DA; Russell WC; Akusjärvi G
EMBO J; 1999 Feb; 18(4):1014-24. PubMed ID: 10022843
[TBL] [Abstract][Full Text] [Related]
5. Both phosphorylation and dephosphorylation of ASF/SF2 are required for pre-mRNA splicing in vitro.
Cao W; Jamison SF; Garcia-Blanco MA
RNA; 1997 Dec; 3(12):1456-67. PubMed ID: 9404896
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus E4 open reading frame 4 protein autoregulates E4 transcription by inhibiting E1A transactivation of the E4 promoter.
Bondesson M; Ohman K; Manervik M; Fan S; Akusjärvi G
J Virol; 1996 Jun; 70(6):3844-51. PubMed ID: 8648720
[TBL] [Abstract][Full Text] [Related]
7. Human splicing factor ASF/SF2 encodes for a repressor domain required for its inhibitory activity on pre-mRNA splicing.
Dauksaite V; Akusjärvi G
J Biol Chem; 2002 Apr; 277(15):12579-86. PubMed ID: 11801589
[TBL] [Abstract][Full Text] [Related]
8. Early region 4 modulates adenovirus DNA replication by two genetically separable mechanisms.
Medghalchi S; Padmanabhan R; Ketner G
Virology; 1997 Sep; 236(1):8-17. PubMed ID: 9299612
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of essential splicing factor ASF/SF2 blocks the temporal shift in adenovirus pre-mRNA splicing and reduces virus progeny formation.
Molin M; Akusjärvi G
J Virol; 2000 Oct; 74(19):9002-9. PubMed ID: 10982344
[TBL] [Abstract][Full Text] [Related]
10. The second RNA-binding domain of the human splicing factor ASF/SF2 is the critical domain controlling adenovirus E1A alternative 5'-splice site selection.
Dauksaite V; Akusjärvi G
Biochem J; 2004 Jul; 381(Pt 2):343-50. PubMed ID: 15068396
[TBL] [Abstract][Full Text] [Related]
11. Identification of a bidirectional splicing enhancer: differential involvement of SR proteins in 5' or 3' splice site activation.
Bourgeois CF; Popielarz M; Hildwein G; Stevenin J
Mol Cell Biol; 1999 Nov; 19(11):7347-56. PubMed ID: 10523623
[TBL] [Abstract][Full Text] [Related]
12. The SR splicing factors ASF/SF2 and SC35 have antagonistic effects on intronic enhancer-dependent splicing of the beta-tropomyosin alternative exon 6A.
Gallego ME; Gattoni R; Stévenin J; Marie J; Expert-Bezançon A
EMBO J; 1997 Apr; 16(7):1772-84. PubMed ID: 9130721
[TBL] [Abstract][Full Text] [Related]
13. hnRNP A1 and the SR proteins ASF/SF2 and SC35 have antagonistic functions in splicing of beta-tropomyosin exon 6B.
Expert-Bezançon A; Sureau A; Durosay P; Salesse R; Groeneveld H; Lecaer JP; Marie J
J Biol Chem; 2004 Sep; 279(37):38249-59. PubMed ID: 15208309
[TBL] [Abstract][Full Text] [Related]
14. Functional inactivation of the SR family of splicing factors during a vaccinia virus infection.
Huang TS; Nilsson CE; Punga T; Akusjarvi G
EMBO Rep; 2002 Nov; 3(11):1088-93. PubMed ID: 12393754
[TBL] [Abstract][Full Text] [Related]
15. The subcellular localization of SF2/ASF is regulated by direct interaction with SR protein kinases (SRPKs).
Koizumi J; Okamoto Y; Onogi H; Mayeda A; Krainer AR; Hagiwara M
J Biol Chem; 1999 Apr; 274(16):11125-31. PubMed ID: 10196197
[TBL] [Abstract][Full Text] [Related]
16. Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506.
Pilch B; Allemand E; Facompré M; Bailly C; Riou JF; Soret J; Tazi J
Cancer Res; 2001 Sep; 61(18):6876-84. PubMed ID: 11559564
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation-dephosphorylation differentially affects activities of splicing factor ASF/SF2.
Xiao SH; Manley JL
EMBO J; 1998 Nov; 17(21):6359-67. PubMed ID: 9799243
[TBL] [Abstract][Full Text] [Related]
18. Deletion of the N-terminus of SF2/ASF permits RS-domain-independent pre-mRNA splicing.
Shaw SD; Chakrabarti S; Ghosh G; Krainer AR
PLoS One; 2007 Sep; 2(9):e854. PubMed ID: 17786225
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus early region 4 promotes the localization of splicing factors and viral RNA in late-phase interchromatin granule clusters.
Bridge E; Mattsson K; Aspegren A; Sengupta A
Virology; 2003 Jun; 311(1):40-50. PubMed ID: 12832201
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of the SR proteins 9G8, SC35, ASF/SF2, and SRp40 on the utilization of the A1 to A5 splicing sites of HIV-1 RNA.
Ropers D; Ayadi L; Gattoni R; Jacquenet S; Damier L; Branlant C; Stévenin J
J Biol Chem; 2004 Jul; 279(29):29963-73. PubMed ID: 15123677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
